PBIO

Pressure BioSciences, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 10/03/2016
Contact Info
  • 14 Norfolk Avenue
  • South Easton, MA 02375

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
Regulatory Agency Financial Industry Regulatory Authority
CIK 0000830656
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3826 - Analytical instruments
Business Status Development Stage Company a/o
Incorporated In: MA, USA
Year of Inc. 2004
Employees 9 a/o Nov 09, 2014
Company Officers/Contacts
Richard T. Schumacher CEO, President, Acting CFO
Edmund Ting Senior VP, Engineering
Alexander Lazarev VP, R&D
Nathan P. Lawrence VP, Sales & Mktg.
Company Directors
Jeffrey N. Peterson Chairman
Vito J. Mangiardi
Kevin A. Pollack
Michael S. Urdea
Company Notes
  • Formerly=Boston Biomedica, Inc. until 9-04
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States

Legal Counsel
Lucosky Brookman LLP
101 Wood Avenue South
5th Floor
Woodbridge, NJ, 08830
United States

Investor Relations Firm
Not Available
PBIO Security Details
Share Structure
Market Value1 $9,260,659 a/o Dec 02, 2016
Authorized Shares 100,000,000 a/o Sep 30, 2016
Outstanding Shares 30,868,862 a/o Nov 11, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Shareholders
Shareholders of Record 212 a/o Apr 05, 2016
Short Selling Data
Short Interest 7,132 (-80.52%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security